Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG) and Teva Pharmaceutical Industries (TEVA)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intuitive Surgical (ISRG) and Teva Pharmaceutical Industries (TEVA).

Intuitive Surgical (ISRG)

In a report issued on December 6, Larry Biegelsen from Wells Fargo maintained a Buy rating on Intuitive Surgical. The company’s shares closed last Monday at $585.57, close to its 52-week high of $594.17.

According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 15.1% and a 69.4% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Edwards Lifesciences.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $618.00 average price target.

See today’s analyst top recommended stocks >>

Teva Pharmaceutical Industries (TEVA)

Wells Fargo analyst David Maris maintained a Hold rating on Teva Pharmaceutical Industries on December 6. The company’s shares closed last Monday at $9.92.

According to TipRanks.com, Maris is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -6.3% and a 37.2% success rate. Maris covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Bausch Health Companies, and Emergent Biosolutions.

Currently, the analyst consensus on Teva Pharmaceutical Industries is a Hold with an average price target of $8.78.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts